Nguyen
05-09-2022, 03:30 PM
I think the key new Enhetu info is the unexpected efficacy with respect to brain met.
Nguyen
Enhertu additional analyses further reinforce ground-breaking efficacy in patients with HER2-positive metastatic breast cancer
https://www.astrazeneca.com/media-centre/press-releases/2021/enhertu-additional-analyses-further-reinforce-ground-breaking-efficacy-in-patients-with-her2-positive-metastatic-breast-cancer.html
Nguyen
Enhertu additional analyses further reinforce ground-breaking efficacy in patients with HER2-positive metastatic breast cancer
https://www.astrazeneca.com/media-centre/press-releases/2021/enhertu-additional-analyses-further-reinforce-ground-breaking-efficacy-in-patients-with-her2-positive-metastatic-breast-cancer.html